These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6124297)

  • 1. Effect of chronic ranitidine treatment on secretion of intrinsic factor.
    Yeomans ND; Hanson RG; Smallwood RA; Mihaly GW; Louis WJ
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):264. PubMed ID: 6124297
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chronic ranitidine treatment on secretion of intrinsic factor.
    Belaiche J; Zittoun J
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):890-1. PubMed ID: 6126246
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ranitidine on secretion of gastric intrinsic factor and absorption of vitamin B 12].
    Bélaïche J; Zittoun J; Marquet J; Nurit Y; Yvart J
    Gastroenterol Clin Biol; 1983 Apr; 7(4):381-4. PubMed ID: 6135642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion.
    Mohammed R; Clark JS; Adams JF; Hearns JB; Crean GP
    Clin Ther; 1981; 4(2):118-20. PubMed ID: 6117373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.
    Peden NR; Saunders JH; Wormsley KG
    Lancet; 1979 Mar; 1(8118):690-2. PubMed ID: 85934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ranitidine and cimetidine on pentagastrin and insulin stimulated gastric secretion.
    Sheers R; Roberts N
    Scand J Gastroenterol Suppl; 1981 Jun; 69():51-9. PubMed ID: 6119783
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion].
    Del Vecchio-Blanco C; Loguercio C; Caporaso N; de Sio I; Romano M; Focareta R; Taranto D
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):331-6. PubMed ID: 9704131
    [No Abstract]   [Full Text] [Related]  

  • 12. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of H2-receptor antagonists on pepsin secretion in man.
    Gledhill T; Hunt RH
    Prog Clin Biol Res; 1985; 173():159-67. PubMed ID: 2858865
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa.
    Ribet A; Balas D; Bastie MJ; Senegas-Balas F; Escourrou J; Bommelaer G; Pradayrol L
    Scand J Gastroenterol Suppl; 1981; 70():155-74. PubMed ID: 6118944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study with ranitidine and cimetidine on gastric secretion.
    Sewing KF; Billian A; Malchow H
    Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Ohtsuki H; Okabe S
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
    Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the new H2-receptor antagonist ranitidine on plasma prolactin levels in duodenal ulcer patients.
    Robins AH; McFadyen ML
    J Pharm Pharmacol; 1981 Sep; 33(9):615-6. PubMed ID: 6117649
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.
    Mohammed R; Holden RJ; Hearns JB; McKibben BM; Buchanan KD; Crean GP
    Gut; 1983 Jan; 24(1):61-6. PubMed ID: 6129180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral ranitidine: onset and duration of action.
    Dammann HG; Müller P; Simon B
    Br J Anaesth; 1982 Nov; 54(11):1235-6. PubMed ID: 6128015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.